Vericel
VCEL
$47.83
Share price
-0.10%
Change (1 day)
48.91%
Change (1 year)
Categories
P/S ratio for Vericel (VCEL)
P/S ratio as of May 2024 (TTM): 11.7
According to Vericel 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.728. At the end of 2023 the company had a P/S ratio of 8.60.
P/S ratio history for Vericel from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 8.60 | 13.7% |
| 2022 | 7.57 | -35.76% |
| 2021 | 11.8 | 4.28% |
| 2020 | 11.3 | 70.55% |
| 2019 | 6.62 | -20.63% |
| 2018 | 8.35 | 180.42% |
| 2017 | 2.98 | 64.26% |
| 2016 | 1.81 | 51.05% |
| 2015 | 1.20 | -52.23% |
| 2014 | 2.51 | -99.69% |
| 2013 | 803 | -69.44% |
| 2012 | > 1000 | -32.75% |
| 2011 | > 1000 | 42.73% |
| 2010 | > 1000 | 1005.08% |
| 2009 | 248 | 49.01% |
| 2008 | 166 | 42.98% |
| 2007 | 116 | -34.69% |
| 2006 | 178 | -47.36% |
| 2005 | 338 | 206.43% |
| 2004 | 110 | 31.73% |
| 2003 | 83.8 | 149.92% |
| 2002 | 33.5 | -46.05% |
| 2001 | 62.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Royalty Pharma RPRX | 7.30 | -37.78% | 🇬🇧 UK |
 Neogen NEOG | 2.90 | -75.25% | 🇺🇸 USA |